Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 238

  • Showing results for houssami n. Search instead for Hussami N (1 item)
1.

Preoperative breast cancer staging with multi-modality imaging and surgical outcomes.

Mariscotti G, Durando M, Tagliafico A, Campanino PP, Bosco D, Casella C, Bussone R, Ala A, Castellano I, Sapino A, Bergamasco L, Fonio P, Houssami N.

Eur J Radiol. 2020 Jan;122:108766. doi: 10.1016/j.ejrad.2019.108766. Epub 2019 Nov 22.

PMID:
31809942
2.

Overview of radiomics in breast cancer diagnosis and prognostication.

Tagliafico AS, Piana M, Schenone D, Lai R, Massone AM, Houssami N.

Breast. 2019 Nov 6;49:74-80. doi: 10.1016/j.breast.2019.10.018. [Epub ahead of print]

3.

The ethical, legal and social implications of using artificial intelligence systems in breast cancer care.

Carter SM, Rogers W, Win KT, Frazer H, Richards B, Houssami N.

Breast. 2019 Oct 11;49:25-32. doi: 10.1016/j.breast.2019.10.001. [Epub ahead of print]

4.

Effect of implementing digital breast tomosynthesis (DBT) instead of mammography on population screening outcomes including interval cancer rates: Results of the Trento DBT pilot evaluation.

Bernardi D, Gentilini MA, De Nisi M, Pellegrini M, Fantò C, Valentini M, Sabatino V, Luparia A, Houssami N.

Breast. 2019 Sep 30. pii: S0960-9776(19)30561-2. doi: 10.1016/j.breast.2019.09.012. [Epub ahead of print]

5.

Breast cancer.

Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, Ruddy K, Tsang J, Cardoso F.

Nat Rev Dis Primers. 2019 Sep 23;5(1):66. doi: 10.1038/s41572-019-0111-2. Review.

PMID:
31548545
6.

Pathways to breast cancer screening artificial intelligence algorithm validation.

Lee CI, Houssami N, Elmore JG, Buist DSM.

Breast. 2019 Sep 9. pii: S0960-9776(19)30554-5. doi: 10.1016/j.breast.2019.09.005. [Epub ahead of print]

7.

Intraoperative digital breast tomosynthesis using a dedicated device is more accurate than standard intraoperative mammography for identifying positive margins.

Garlaschi A, Fregatti P, Oddone C, Friedman D, Houssami N, Calabrese M, Tagliafico AS.

Clin Radiol. 2019 Dec;74(12):974.e1-974.e6. doi: 10.1016/j.crad.2019.08.004. Epub 2019 Sep 11.

PMID:
31521327
8.

Pilot trial of digital breast tomosynthesis (3D mammography) for population-based screening in BreastScreen Victoria.

Houssami N, Lockie D, Clemson M, Pridmore V, Taylor D, Marr G, Evans J, Macaskill P.

Med J Aust. 2019 Oct;211(8):357-362. doi: 10.5694/mja2.50320. Epub 2019 Aug 26.

PMID:
31448816
9.

Breast cancer Ki-67 expression prediction by digital breast tomosynthesis radiomics features.

Tagliafico AS, Bignotti B, Rossi F, Matos J, Calabrese M, Valdora F, Houssami N.

Eur Radiol Exp. 2019 Aug 14;3(1):36. doi: 10.1186/s41747-019-0117-2.

10.

Improving breast cancer screening in Australia: a public health perspective.

Nickson C, Velentzis LS, Brennan P, Mann GB, Houssami N.

Public Health Res Pract. 2019 Jul 31;29(2). pii: 2921911. doi: 10.17061/phrp2921911.

11.

Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial.

Hofvind S, Holen ÅS, Aase HS, Houssami N, Sebuødegård S, Moger TA, Haldorsen IS, Akslen LA.

Lancet Oncol. 2019 Jun;20(6):795-805. doi: 10.1016/S1470-2045(19)30161-5. Epub 2019 May 8. Erratum in: Lancet Oncol. 2019 Jul;20(7):e346.

PMID:
31078459
12.

Artificial Intelligence (AI) for the early detection of breast cancer: a scoping review to assess AI's potential in breast screening practice.

Houssami N, Kirkpatrick-Jones G, Noguchi N, Lee CI.

Expert Rev Med Devices. 2019 May;16(5):351-362. doi: 10.1080/17434440.2019.1610387. Epub 2019 May 3. Review.

PMID:
30999781
13.

Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? - A cost-effectiveness analysis.

Phi XA, Greuter MJW, Obdeijn IM, Oosterwijk JC, Feenstra TL, Houssami N, de Bock GH.

Breast. 2019 Jun;45:82-88. doi: 10.1016/j.breast.2019.03.004. Epub 2019 Mar 12.

PMID:
30904701
14.

Towards evidence-based follow-up intervals for breast cancer survivors: Estimates of the preclinical detectable phase of contralateral second breast cancer.

Aarts AMWM, Duffy SW, Geurts SME, Vulkan DP, Houssami N, Zappa M, Nagtegaal ID, Verbeek ALM, Broeders MJM.

Breast. 2019 Jun;45:70-74. doi: 10.1016/j.breast.2019.03.003. Epub 2019 Mar 8.

PMID:
30884341
15.

Metastatic breast cancer incidence, site and survival in Australia, 2001-2016: a population-based health record linkage study protocol.

Lord SJ, Kiely BE, Pearson SA, Daniels B, O'Connell DL, Beith J, Bulsara MK, Houssami N.

BMJ Open. 2019 Feb 1;9(2):e026414. doi: 10.1136/bmjopen-2018-026414.

16.

Agreement between digital breast tomosynthesis and pathologic tumour size for staging breast cancer, and comparison with standard mammography.

Marinovich ML, Bernardi D, Macaskill P, Ventriglia A, Sabatino V, Houssami N.

Breast. 2019 Feb;43:59-66. doi: 10.1016/j.breast.2018.11.001. Epub 2018 Nov 10.

PMID:
30466027
17.

A prospective comparative trial of adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts (ASTOUND-2).

Tagliafico AS, Mariscotti G, Valdora F, Durando M, Nori J, La Forgia D, Rosenberg I, Caumo F, Gandolfo N, Sormani MP, Signori A, Calabrese M, Houssami N.

Eur J Cancer. 2018 Nov;104:39-46. doi: 10.1016/j.ejca.2018.08.029. Epub 2018 Oct 11.

PMID:
30316869
18.

The impact of legislation mandating breast density notification - Review of the evidence.

Houssami N, Lee CI.

Breast. 2018 Dec;42:102-112. doi: 10.1016/j.breast.2018.09.001. Epub 2018 Sep 11. Review.

19.

A randomized controlled trial of digital breast tomosynthesis versus digital mammography in population-based screening in Bergen: interim analysis of performance indicators from the To-Be trial.

Aase HS, Holen ÅS, Pedersen K, Houssami N, Haldorsen IS, Sebuødegård S, Hanestad B, Hofvind S.

Eur Radiol. 2019 Mar;29(3):1175-1186. doi: 10.1007/s00330-018-5690-x. Epub 2018 Aug 29.

20.

Effect of integrating digital breast tomosynthesis (3D-mammography) with acquired or synthetic 2D-mammography on radiologists' true-positive and false-positive detection in a population screening trial: A descriptive study.

Bernardi D, Li T, Pellegrini M, Macaskill P, Valentini M, Fantò C, Ostillio L, Houssami N.

Eur J Radiol. 2018 Sep;106:26-31. doi: 10.1016/j.ejrad.2018.07.008. Epub 2018 Jul 10.

PMID:
30150047

Supplemental Content

Loading ...
Support Center